Posts By :

Shawn Haigh

Shawn Haigh

Journal watch: Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases

850 567 Shawn Haigh

The Background 2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET) is a commonly used method to detect regional reductions in brain glucose uptake typically observed in patients with Alzheimer’s disease (AD) and other…

read more

Journal watch: Effect of cannabidiol on interictal epileptiform activity and sleep architecture in children with intractable epilepsy: A prospective open-label study

1500 1000 Shawn Haigh

The Background Cannabidiol was used increasingly over the last 5 years in the therapy of epilepsy and has shown to be effective in reducing seizures in patients with Dravet syndrome,…

read more

What are the implications for the third COVID-19 vaccine on CD-20-depleted people with MS – Oliver Findling reports

1500 1001 Shawn Haigh

In a guest post on “The MS Blog,” Dr Oliver Findling summarised a recent study on which he was the principal investigator: Humoral Immune Response after the Third SARS-CoV-2 mRNA…

read more

The female stroke: Sex differences affect stroke presentation and management

1000 562 Shawn Haigh

Women have a unique experience when it comes to stroke. Several differences between the sexes exist in stroke; in the epidemiology of the disease, clinical presentation, medical care and patient…

read more

Understanding seizure cyclicity: Possible benefits for epilepsy management?

2000 1334 Shawn Haigh

Over millennia, humans have tried to unveil the mechanisms behind epileptic seizure cyclicity.1 Despite patients with epilepsy often experiencing seizures at consistent times of the day, week, month, or year,…

read more

Journal watch: The long-term effects of COVID-19

1248 832 Shawn Haigh

The Background The acute clinical manifestations of coronavirus disease 2019 (COVID-19) have been well established. Looking beyond this acute setting, reports have suggested that some people with COVID-19 may experience…

read more

Vaccines and MS – are they still effective?

1000 662 Shawn Haigh

During the coronavirus disease 2019 (COVID-19) pandemic, vaccines have been at the forefront of the public consciousness. This is especially true for individuals with multiple sclerosis (MS), as some may…

read more
Brainwork is supported by unrestricted grants from: